Bertrand Loy - 21 May 2024 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Reporting relationship: Director
Issuer ticker: HBIO
Reported as of: 21 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 May 2024, 16:24:21 UTC
Prior SEC filing: 03 Apr 2024
Next SEC filing: 08 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ John Fry, by power of attorney

Key filing fact

Bertrand Loy filed Form 4 for HARVARD BIOSCIENCE INC (HBIO) on 23 May 2024.

Key facts

This page summarizes Bertrand Loy's Form 4 filing for HARVARD BIOSCIENCE INC (HBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 May 2024, 16:24.

Change

Previous filing in this sequence was filed on 03 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HBIO transaction

Common Stock

Award

Transaction value: $0
Shares: +56,575
Change %
Price: $0.000000
Shares after: 56,575
Date: 21 May 2024
Ownership: Direct
Footnotes: F1

HBIO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 499,633
Date: 21 May 2024
Ownership: by Bertrand M. Loy Revocable Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of 56,575 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 14, 2024, immediately prior to the commencement of such meeting, and (ii) May 21, 2025.